200 related articles for article (PubMed ID: 33685563)
1. Evaluation of drug patch tests in children.
Büyük Yaytokgil Ş; Güvenir H; Külhaş Celík İ; Yilmaz Topal Ö; Karaatmaca B; Civelek E; Toyran M; Dibek Misirlioğlu E
Allergy Asthma Proc; 2021 Mar; 42(2):167-174. PubMed ID: 33685563
[No Abstract] [Full Text] [Related]
2. Aetiopathogenesis of severe cutaneous adverse reactions (SCARs) in children: A 9-year experience in a tertiary care paediatric hospital setting.
Liccioli G; Mori F; Parronchi P; Capone M; Fili L; Barni S; Sarti L; Giovannini M; Resti M; Novembre EM
Clin Exp Allergy; 2020 Jan; 50(1):61-73. PubMed ID: 31608511
[TBL] [Abstract][Full Text] [Related]
3. Long-term reproducibility of positive patch test reactions in patients with non-immediate cutaneous adverse drug reactions to antibiotics.
Pinho A; Marta A; Coutinho I; Gonçalo M
Contact Dermatitis; 2017 Apr; 76(4):204-209. PubMed ID: 27910104
[TBL] [Abstract][Full Text] [Related]
4. Diagnosing nonimmediate reactions to penicillins by in vivo tests.
Romano A; Viola M; Mondino C; Pettinato R; Di Fonso M; Papa G; Venuti A; Montuschi P
Int Arch Allergy Immunol; 2002 Oct; 129(2):169-74. PubMed ID: 12403935
[TBL] [Abstract][Full Text] [Related]
5. Antibiotic allergies in children and adults: from clinical symptoms to skin testing diagnosis.
Romano A; Caubet JC
J Allergy Clin Immunol Pract; 2014; 2(1):3-12. PubMed ID: 24565763
[TBL] [Abstract][Full Text] [Related]
6. Clindamycin-induced Maculopapular Exanthema with Preferential Involvement of Striae Distensae: A Koebner phenomenon?
Monteagudo B; Cabanillas M; Iriarte P; Ramírez-Santos A; León-Muinos E; González-Vilas D; Suárez-Amor Ó
Acta Dermatovenerol Croat; 2018 Apr; 26(1):61-63. PubMed ID: 29782303
[TBL] [Abstract][Full Text] [Related]
7. Severe Cutaneous Adverse Drug Reactions in Pediatric Patients: A Multicenter Study.
Dibek Misirlioglu E; Guvenir H; Bahceci S; Haktanir Abul M; Can D; Usta Guc BE; Erkocoğlu M; Toyran M; Nacaroglu HT; Civelek E; Buyuktiryaki B; Ginis T; Orhan F; Kocabas CN
J Allergy Clin Immunol Pract; 2017; 5(3):757-763. PubMed ID: 28351788
[TBL] [Abstract][Full Text] [Related]
8. [Epicutaneous patch testing in delayed drug hypersensitivity reactions induced by antiepileptic drugs].
Ben Mahmoud L; Bahloul N; Ghozzi H; Kammoun B; Hakim A; Sahnoun Z; Kammoun S; Zeghal K
Therapie; 2017 Oct; 72(5):539-545. PubMed ID: 28416298
[TBL] [Abstract][Full Text] [Related]
9. [Drug patch tests in the investigation of cutaneous adverse drug reactions].
Barbaud A
Ann Dermatol Venereol; 2009; 136(8-9):635-44. PubMed ID: 19686903
[TBL] [Abstract][Full Text] [Related]
10. Drug patch testing in systemic cutaneous drug allergy.
Barbaud A
Toxicology; 2005 Apr; 209(2):209-16. PubMed ID: 15767038
[TBL] [Abstract][Full Text] [Related]
11. Allergy to betalactam antibiotics in children: results of a 20-year study based on clinical history, skin and challenge tests.
Ponvert C; Perrin Y; Bados-Albiero A; Le Bourgeois M; Karila C; Delacourt C; Scheinmann P; De Blic J
Pediatr Allergy Immunol; 2011 Jun; 22(4):411-8. PubMed ID: 21535179
[TBL] [Abstract][Full Text] [Related]
12. Diagnosing hypersensitivity reactions to cephalosporins in children.
Romano A; Gaeta F; Valluzzi RL; Alonzi C; Viola M; Bousquet PJ
Pediatrics; 2008 Sep; 122(3):521-7. PubMed ID: 18762521
[TBL] [Abstract][Full Text] [Related]
13. Patch testing in drug allergy.
Friedmann PS; Ardern-Jones M
Curr Opin Allergy Clin Immunol; 2010 Aug; 10(4):291-6. PubMed ID: 20485160
[TBL] [Abstract][Full Text] [Related]
14. Patch tests in nonimmediate cutaneous adverse drug reactions: The importance of late readings on day 4.
Bhujoo Z; Ingen-Housz-Oro S; Gener G; Gaudin O; Fleck M; Verlinde-Carvalho M; Paul M; Chosidow O; Wolkenstein P; Assier H
Contact Dermatitis; 2022 Jan; 86(1):29-33. PubMed ID: 34590309
[TBL] [Abstract][Full Text] [Related]
15. Role of in vivo and in vitro Tests in the Diagnosis of Severe Cutaneous Adverse Reactions (SCAR) to Drug.
Bergmann MM; Caubet JC
Curr Pharm Des; 2019; 25(36):3872-3880. PubMed ID: 31696801
[TBL] [Abstract][Full Text] [Related]
16. Skin testing and patch testing in non-IgE-mediated drug allergy.
Barbaud A
Curr Allergy Asthma Rep; 2014 Jun; 14(6):442. PubMed ID: 24740692
[TBL] [Abstract][Full Text] [Related]
17. Allergy to beta-lactam antibiotics in children.
Ponvert C; Le Clainche L; de Blic J; Le Bourgeois M; Scheinmann P; Paupe J
Pediatrics; 1999 Oct; 104(4):e45. PubMed ID: 10506270
[TBL] [Abstract][Full Text] [Related]
18. The Role of In Vivo and Ex Vivo Diagnostic Tools in Severe Delayed Immune-Mediated Adverse Antibiotic Drug Reactions.
Copaescu A; Mouhtouris E; Vogrin S; James F; Chua KYL; Holmes NE; Douglas A; Slavin MA; Cleland H; Zubrinich C; Aung AK; Goh MSY; Phillips EJ; Trubiano JA;
J Allergy Clin Immunol Pract; 2021 May; 9(5):2010-2015.e4. PubMed ID: 33453452
[TBL] [Abstract][Full Text] [Related]
19. Patch testing in severe cutaneous adverse drug reactions, including Stevens-Johnson syndrome and toxic epidermal necrolysis.
Wolkenstein P; Chosidow O; Fléchet ML; Robbiola O; Paul M; Dumé L; Revuz J; Roujeau JC
Contact Dermatitis; 1996 Oct; 35(4):234-6. PubMed ID: 8957644
[TBL] [Abstract][Full Text] [Related]
20. The Role of Patch Testing in Evaluating Delayed Hypersensitivity Reactions to Medications.
Woodruff CM; Botto N
Clin Rev Allergy Immunol; 2022 Jun; 62(3):548-561. PubMed ID: 35113364
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]